Literature DB >> 17216595

Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia.

Robert K Nuttall1, Claudia Silva, Walter Hader, Amit Bar-Or, Kamala D Patel, Dylan R Edwards, V Wee Yong.   

Abstract

Microglia are resident immune cells within the central nervous system (CNS). They become activated following neurological insults and increase their expression of cytokines. Also elevated in CNS injuries are proteases, including matrix metalloproteinases (MMPs) and A disintegrin and metalloproteinases (ADAMs). The spectrum of metalloproteinase members expressed by microglia and by the systemic leukocytes that infiltrate the injured CNS is unknown, as are their functions. We determined the levels of transcripts encoding all 24 MMPs, nine ADAMs, and their four physiological antagonists, tissue inhibitor of metalloproteinases (TIMPs), in human microglia, B and T cells, monocytes, and neutrophils. We found a distinct pattern for each immune subset and an enrichment of metalloproteinases in microglia compared with leukocytes. When microglia were activated, there was an upregulation of transcripts for nine metalloproteinases, and reduction of TIMP3. Activation of microglia also resulted in increased levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-10 protein in the conditioned media of cells. The amount of secreted TNF-alpha, but not IL-1beta or IL-10, was suppressed by BB94, a broad spectrum metalloproteinase inhibitor, and by TIMP3 but not TIMP1 or TIMP2. This inhibitory profile suggests the involvement of an ADAM member in TNF-alpha secretion. We conclude that microglia bear a metalloproteinase signature distinct from systemic cells, and that following activation, microglia upregulate TNF-alpha protein levels through a combination of elevated cytokine transcripts, increased metalloproteinase level and activity, and through the decrease of TIMP3. The results have implications for the regulation of neuroinflammation and its outcomes following CNS injuries. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216595     DOI: 10.1002/glia.20478

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  40 in total

1.  A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.

Authors:  Hyo Jin Son; Ji Ae Lee; Nari Shin; Ji Hyun Choi; Jai Woong Seo; Dae Yoon Chi; Cheol Soon Lee; Eun-Mee Kim; Han Choe; Onyou Hwang
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Induction of matrix metalloproteinase-3 (MMP-3) expression in the microglia by lipopolysaccharide (LPS) via upregulation of glycoprotein nonmetastatic melanoma B (GPNMB) expression.

Authors:  Fangyuan Shi; Shuangyan Duan; Jihong Cui; Xingrong Yan; Hongmin Li; Yingjuan Wang; Fulin Chen; Lihua Zhang; Jun Liu; Xin Xie
Journal:  J Mol Neurosci       Date:  2014-03-30       Impact factor: 3.444

3.  Newborn screening for autism: in search of candidate biomarkers.

Authors:  Gerald J Mizejewski; Barbara Lindau-Shepard; Kenneth A Pass
Journal:  Biomark Med       Date:  2013-04       Impact factor: 2.851

Review 4.  Myeloid cells - targets of medication in multiple sclerosis.

Authors:  Manoj K Mishra; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

5.  Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells.

Authors:  S E Park; K Sapkota; S Kim; H Kim; S J Kim
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism.

Authors:  C A Christianson; B L Fitzsimmons; J-H Shim; A Agrawal; S M Cohen; X-Y Hua; T L Yaksh
Journal:  Neuroscience       Date:  2011-10-20       Impact factor: 3.590

7.  Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage.

Authors:  Patrick Wunderlich; Konstantin Glebov; Nadja Kemmerling; Nguyen T Tien; Harald Neumann; Jochen Walter
Journal:  J Biol Chem       Date:  2013-09-27       Impact factor: 5.157

Review 8.  Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.

Authors:  E Candelario-Jalil; Y Yang; G A Rosenberg
Journal:  Neuroscience       Date:  2008-06-19       Impact factor: 3.590

Review 9.  Targeting MMPs in acute and chronic neurological conditions.

Authors:  V Wee Yong; Smriti M Agrawal; David P Stirling
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

10.  Phosphoinositide 3-kinase γ affects LPS-induced disturbance of blood-brain barrier via lipid kinase-independent control of cAMP in microglial cells.

Authors:  Adrian Frister; Caroline Schmidt; Nadine Schneble; Michael Brodhun; Falk A Gonnert; Michael Bauer; Emilio Hirsch; Jörg P Müller; Reinhard Wetzker; Reinhard Bauer
Journal:  Neuromolecular Med       Date:  2014-07-18       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.